[1]
. X. Zhang, J. Tong, Z. Wang, and H. Yang, “Comparison of the Effects of Zoledronic Acid versus Denosumab on Bone Metabolism, Inflammatory Response, and Immunoglobulins in Breast Cancer Patients with Bone Metastases”, J Med Biochem, vol. 44, no. 4, pp. 731–739, Mar. 2025, doi: 10.5937/jomb0-56984.